Epidemiology and Perinatal Outcomes of Antiphospholipid Antibodies in Pregnancies Complicated by Placental Syndrome in a tertiary care hospital in Thailand: A Cross Sectional Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260309009

Enrollment

Registered

2026-03-09

Start date

2026-03-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidemiology and Perinatal Outcomes of Antiphospholipid Antibodies in Pregnancies Complicated by Placental Syndrome in a tertiary care hospital in Thailand Epidemiology, Perinatal Outcomes, Antiphospholipid Antibodies, Pregnancies

Interventions

prenancy women with positive of antiphospholipid antibodies

Screening

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pregnant women with singleton or twin pregnancies Age more than 18 years, Diagnosis of early-onset preeclampsia before 34 weeks of gestation and/or fetal growth restriction (FGR)

Exclusion criteria

Exclusion criteria: Fetuses with major congenital anomalies, Incomplete data on pregnancy and delivery, Participants who decline to participate in the study

Design outcomes

Primary

Measure	Time frame
Prevalence 12 month percent	—

Secondary

Measure	Time frame
Perinatal outcome 12 montg Odds ratio	—

Countries

Thailand

Contacts

Public ContactNititorn Khantawichai

Khon Kaen

abcdeton_412@hotmail.com0980970807

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026